Search - tctmd.com

Displaying 941 - 960 of 960

Sort: Relevancy | Date

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Conference News

STACCATO: Transapical TAVR Inferior to Surgery for Operable Elderly Patients

November 09, 2011

News Conference News

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

November 09, 2011

News Conference News

PARTNER A: Transfemoral TAVR Improved QOL, Costs vs. Surgery

November 09, 2011

News Conference News

Complications After TAVR: Manageable, But Important to Consider

November 09, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Conference News

ZES and SES Equally Effective in Long Lesion Treatment

November 08, 2011

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

News Conference News

Mitral, Aortic Regurgitation Increase Mortality After Transcatheter Valve Replacement

November 08, 2011

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

News Conference News

Caution Urged in Widespread Adoption of TAVR

November 08, 2011

News Conference News

SAT-TAVI: Data Support TAVR Without Dual Antiplatelet Therapy

November 07, 2011

News Conference News

SAPPHIRE and CABANA Add More Validation for Carotid Artery Stenting

November 07, 2011

News Conference News

Novel Imaging Modality Used to Assess Effect of Thrombus Aspiration in STEMI

November 07, 2011

News Conference News

Debate: PCI vs. CABG for Left Main Disease

November 07, 2011

News Conference News

No Change Seen in European TAVR Clinical Use Patterns

November 06, 2011

Video

» Interview

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

September 18, 2022

Video

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

September 29, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Vinod Thourani About PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Jonas Lanz About SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

September 26, 2019

Advertisement

Two New SES Show Improvement Over First-Generation Stents

STACCATO: Transapical TAVR Inferior to Surgery for Operable Elderly Patients

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

PARTNER A: Transfemoral TAVR Improved QOL, Costs vs. Surgery

Complications After TAVR: Manageable, But Important to Consider

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

ZES and SES Equally Effective in Long Lesion Treatment

Preclinical Results Promising for Combo Stent

Mitral, Aortic Regurgitation Increase Mortality After Transcatheter Valve Replacement

EES Compared Favorably with SES In Two Pivotal Trials

Caution Urged in Widespread Adoption of TAVR

SAT-TAVI: Data Support TAVR Without Dual Antiplatelet Therapy

SAPPHIRE and CABANA Add More Validation for Carotid Artery Stenting

Novel Imaging Modality Used to Assess Effect of Thrombus Aspiration in STEMI

Debate: PCI vs. CABG for Left Main Disease

No Change Seen in European TAVR Clinical Use Patterns

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Dr. C. Michael Gibson Talks With Dr. Vinod Thourani About PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Dr. C. Michael Gibson Talks With Dr. Jonas Lanz About SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content